Vector-borne Disease Agent Surveillance Research & Development in External Proficiency Testing

SOL #: HT942626RE023Combined Synopsis/Solicitation

Overview

Buyer

DEPT OF DEFENSE
Defense Health Agency (Dha)
DEFENSE HEALTH AGENCY
FORT DETRICK, MD, 21702, United States

Place of Performance

MD

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

Reference Laboratory Testing (Q301)

Set Aside

No set aside specified

Timeline

1
Posted
Jun 9, 2026
2
Submission Deadline
Jun 29, 2026, 2:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Defense Health Agency (DHA), specifically the Theater Preventive Medicine Flight, 18th Medical Group, Kadena Air Force Base, is soliciting proposals for Vector-borne Disease Agent Surveillance Research & Development in External Proficiency Testing. This Combined Synopsis/Solicitation seeks non-personal services to develop and validate external proficiency testing procedures for pathogen detection in arthropods. The contract will be a Single Firm Fixed Price (FFP). Quotes are due June 29, 2026, at 10:00 AM EDT.

Scope of Work

The primary objective is to develop safe and validated external proficiency testing procedures for detecting pathogens in arthropods (e.g., ticks, mosquitoes) using non-infectious agents, supporting reliable diagnostic capabilities through external quality assurance. Key deliverables include:

  • Developing a comprehensive manual/SOP for creating, preparing, and using safe, transportable external quality assurance/proficiency test materials, focusing on partial nucleic acid constructs or synthetic/non-infectious materials (e.g., Dengue virus via qRT-PCR).
  • Validating the developed protocol to establish performance specifications (accuracy, precision, sensitivity, specificity).
  • Demonstrating proficiency test performance characteristics (LOD, sensitivity, specificity) using a minimum of 60 samples.
  • Conducting an initial analysis of the protocol's capability for field-expedient conditions (stability, transportability, robustness).
  • Providing monthly progress reports and a final comprehensive closeout report.
  • Supporting molecular assays (PCR, multiplex PCR, or NGS) performed by vector surveillance laboratories.

Contract Details

  • Contract Type: Single Firm Fixed Price (FFP).
  • Period of Performance: Anticipated start September 30, 2026, for one 12-month period, ending September 29, 2027.
  • Place of Performance: Contractor's facility.
  • NAICS Code: 541714 (Research and Development in Biotechnology, except Nanobiotechnology).
  • Product Service Code: Q301 (Reference Laboratory Testing).

Submission & Evaluation

  • Questions Due: June 16, 2026, 10:00 AM EDT.
  • Quote Due: June 29, 2026, 10:00 AM EDT.
  • Submission Method: Electronic submission to Benjamin Marcus at benjamin.t.marcus2.civ@health.mil.
  • Quote Content: Two volumes: Volume I: Technical Capabilities (Non-Price, 10-page limit) and Volume II: Price (no page limit).
  • Evaluation Factors: Award will be made on a competitive best-value basis using a Subjective Trade-Off approach. Technical Capabilities will be rated "Acceptable/Unacceptable" and must be "Acceptable" for consideration. Price will be assessed for completeness and reasonableness.

Eligibility / Set-Aside

  • Set-Aside: None specified.
  • Requirements: Offerors must submit completed provisions 52.219-1 and 252.204-7017 (Prohibition on the Acquisition of Covered Defense Telecommunications Equipment or Services-Representation) with their Quote.

Additional Notes

The Performance Work Statement (PWS) details specific deliverables and 100% AQLs for compliance. The Quality Assurance Surveillance Plan (QASP) outlines how contractor performance will be monitored and assessed, emphasizing performance objectives and standards. The Government will provide limited virus-free mosquito samples for confirmation testing, and all data/reports developed are subject to Government unlimited rights.

People

Points of Contact

Benjamin MarcusPRIMARY
Erin MaddoxSECONDARY

Files

Files

Download
Download
Download

Versions

Version 1Viewing
Combined Synopsis/Solicitation
Posted: Jun 9, 2026
Vector-borne Disease Agent Surveillance Research & Development in External Proficiency Testing | GovScope